Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 884 results for "merck co"

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies ...Portuguese ex-premier kept in jail amid fraud case
Yahoo! Finance

Health care M&A leads global deal surge

Related Stocks MRK - Merck & Company Sym Last Chg Pct Volume MRK59.66+0.28+0.47%11,260,300IDIX24.50+0.05+0.20%5,094,300MDT72.49+0.41+0.57%8,974,300 In a big year for deal making, the health care industry is a standout. Large drugmakers are buying ... Barchart, 14 hours ago

49 images for merck co

Yahoo! News, 13 hours ago
Jutia Group, 6 days ago, 2 weeks ago
Bidness Etc, 4 days ago
Live Trading News, 3 weeks ago
Bidness Etc, 5 days ago, 5 days ago
Pharma Letter, 5 days ago
Pharma Letter, 5 days ago, 3 weeks ago

Potential Merck (MRK) Trade Targets 2.35% Return

After ThursdayaEUR(TM)s trading in Merck & Co Inc. ("MRK)'s option trade-picking algorithms uncovered a trade that offers a 2.35% or 5.83% (for comparison purposes only), ...
 Individual.com2 days ago Merck (MRK) Trading Near $58.90 Support Level  Individual.com3 days ago Merck (MRK) Showing Resistance Near $60.70  Individual.com4 days ago Potential Merck (MRK) Trade Has 5.25% Downside Protection  Individual.com6 days ago
Bidness Etc

NewLink Genetics, Merck and Co. (MRK) In Talks To Scale Up Ebola Vaccine Production

Biotech NewLink and pharma giant Merck have reportedly come together to find ways to accelerate production of NewLink's experimental Ebola vaccine Page 1 of 2 Click Ticker to See live coverage NewLink Genetics Corp ( NASDAQ:NLNK ) and ...
 Bidness Etc2 days ago NewLink Said in Talks With Merck & Co. to Produce Ebola Vaccine  Washington Post2 days ago NewLink Said in Talks With Merck on Ebola Vaccine Production  Washington Post3 days ago Merck & Co., NewLink Genetics In Secret Talks On Producing Ebola Vaccine  BioSpace2 days ago
Irish Times

Merck forms global alliance with Pfizer for co- developing cancer drug

As per the agreement, Merck will receive an upfront payment of $ 850 million and is eligible to receive regulatory and commercial milestone payments up to $ 2 billion BS B2B Bureau | Darmstadt, Germany November 18, 2014 Last Updated at 19:38 IST ...
 Business Standard4 days ago Pfizer Cancer Pact With Merck May Show Waning Astra Pursuit  Washington Post6 days ago Pfizer will pay $850m for rights to Merck cancer drug  Irish Times6 days ago Pfizer to Buys Merck KGaA Cancer Drug Rights  Bloomberg6 days ago
Bioresearch Online

Pfizer Links With Merck KGaA In Immuno-Oncology Mega Deal

By Estel Grace Masangkay Pfizer announced that it has signed up with German firm Merck KGaA to co-develop and market an investigational anti-PD-L1 treatment for several types of cancer. As part of the agreement, Pfizer will pay Merck KGaA ...
 Bioresearch Online4 days ago Merck KGaA Ties Up with Pfizer on Immuno-oncology Deal  Yahoo! Finance5 days ago Pfizer Inc. (PFE) Strikes $2.85 Billion Deal With Merck KGaA To Co-Develop Cancer Immunotherapy Drug  Bidness Etc5 days ago Merck, Pfizer strike immunotherapy deal  Deutsche Welle6 days ago
Bidness Etc

Merck and Co.s (MRK) Cholesterol Drug Vytorin Reduced Risk Of Heart Attacks, Study Shows

Mercks Vytorin has been shown to be more effective than simvastatin in reducing the risk of heart attack in patients with prior heart-related complications Page 1 of 2 Click Ticker to See live coverage Merck & Co., Inc.'s ( NYSE:MRK ) ...
 Bidness Etc5 days ago Merck Drug Works: Vytorin Study Proves Successful  Investor's Business Daily6 days ago Merck & Co's LDL-lowering drug Vytorin meets study endpoints  Pharma Letter5 days ago Merck's Vytorin First Cholesterol Drug to Further Cut Heart Risk  Bloomberg6 days ago

You Should Hold Merck According to Dividends Generation

In this article, let's take a look at Merck & Co. Inc. (MRK), a $169.28 billion market cap company, which is one of the world's largest drug makers, acquired Schering-Plough in November 2009. Returning value to shareholders The firm is a leader ...
 Yahoo! Finance2 days ago

Merck partners with Pfizer to co-develop and co-commercialize anti-cancer drug

Merck has entered into an agreement with Pfizer Inc. to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck, as a potential treatment for multiple tumor types. The asset will be ...
 Individual.com2 days ago Esperion Therapeutics, Inc. Climbs As CEO Lauds Merck & Co.'s Zetia Data  BioSpace4 days ago Esperion Therapeutics, Inc. (ESPR) Climbs As CEO Lauds Merck & Co. (MRK)'s Zetia Data 11/19/2014  ClinicSpace4 days ago Merck, Pfizer ink alliance on anti-PD-L1  Center Watch5 days ago
Pharma Letter

Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

NEW YORK--( BUSINESS WIRE )-- Inc. (NYSE:PFE) announced today that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, to jointly develop and commercialize MSB0010718C, an investigational anti-PD-L1 antibody ...
 PressReleasePoint3 days ago Pfizer, Merck ink agreement to jointly develop anti-PD-L1 to accelerate presence in immuno-oncology  PharmaBiz4 days ago Merck enters lucrative cancer alliance with Pfizer17-11-2014  Pharma Letter5 days ago Pfizer, Merck to jointly develop and commercialize new cancer treatments  Pharmaceutical Business Review5 days ago

Medical Breakthroughs On The Horizon For Merck

Summary Merck (MRK) is a global health care company that includes prescription medicines; vaccines, biologic therapies, animal health and consumer care products. 3Q results overshadowed Keytruda receiving a broad breakthrough therapy designation ...
 Seeking Alpha3 days ago MERCK : New Findings on Vaccines Described by Investigators at Merck & Company (Concordance assessment between a multiplexed competitive Luminex...  4 Traders4 days ago Merck Reveals Positive Study Of Pembrolizumab Versus Chemotherapy In Melanoma  Pharmacy Choice6 days ago Merck Announces Positive Study Investigating the Use of Pembrolizumab Compared to Chemotherapy in Patients with Ipilimumab-Refractory Advanced Melanoma  Noodls4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less